Search results
Stocks to Watch Friday: Nvidia, Micron, Sarepta, CarMax
The Wall Street Journal· 4 days ago**Sarepta Therapeutics (SRPT)**: Shares in the biotechnology company rocketed around 35% after the...
Hertz plans $750 million debt offerings to boost liquidity By Investing.com
Investing.com· 5 days agoHertz (NASDAQ:HTZ) Global Holdings (OTC:HTZGQ), Inc. (NASDAQ: HTZ), a prominent player in the global...
Ben Affleck Fumes at Paparazzi While Leaving His and Jennifer Lopez's Marital Home
AceShowbiz· 1 hour agoIn the video obtained and published by TMZ on Monday, June 24, the 51-year-old was driving his car down the driveway on Sunday night while a group of photographers were waiting ...
3 Reasons Why The Mustang Is The Best Car For Summer Loving
AP News Archive· 7 days agoLet me get it out of the way right now: the EcoBoost Mustang does not provide a good soundtrack....
Enjoy Some Paddle Therapy! Join Wanderlust Rentals For A Twilight Paddle Down The Vermilion
KADN· 6 days agoReed Rudasill and Kristopher Guidry of Wanderlust Rentals, stopped by News15 at Noon to share the...
Boise Airport shares plans for $42.5 million expansion
KIVI Boise· 5 days agoThe Boise City Council recently approved the contract which caps the project at $42,465,000 to be...
I drove a Tesla for the first time. It's perfectly fine — but still left me underwhelmed.
Business Insider via Yahoo News· 6 days agoThen there's the realization by some drivers and manufacturers, too, that hybrids might be a better...
These Stocks Moved the Most Today: Nvidia, Microsoft, Trump Media, Sarepta, Palantir, Hertz, Smith &...
Barrons.com· 3 days agoNvidia tumbles after giving up its crown as the world’s most valuable company to Microsoft, Trump...
Hertz Sells $750 Million of Bonds to Strengthen Finances
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Hertz Global Holdings Inc. increased the size of a junk-bond sale by a third to $1...
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 3 days agoShares of the biopharma company surged 30% after the U.S. Food and Drug Administration approved the...